Chimerix, Inc. to Present at Morgan Stanley and Stifel Healthcare Conferences in September

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

DURHAM, N.C., Sept. 6, 2013 (GLOBE NEWSWIRE) -- Chimerix, Inc. (Nasdaq:CMRX), a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, announced today presentations at the following upcoming investor conferences in September:

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC